Global Cardiac Biomarker Market (2021-2026) by Product, Type, Location of Testing, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

The Global Cardiac Biomarker Market is estimated to be USD 3.71 Bn in 2021 and is expected to reach USD 6.99 Bn by 2026, growing at a CAGR of 13. 52%.

Market Dynamics

The factors such as the rise in the number of patients suffering from Acute Coronary Syndrome ACS, the unique features of cardiac biomarker such as showing high accuracy, quick outcomes, and economical pricing of cardiac point of care (POC) testing, and the growing awareness among patients and healthcare providers about the importance of early diagnosis and care of various CVDs is driving the demand for these markers. In addition, the rise in investment in research and development activities by various public and private institutions for the development of advanced technologies in the field of the global cardiac biomarker market is expected to create more opportunities for the growth of the market.

However, the cardiac biomarkers market is facing restraints in the growth of the market due to the development of other methods for diagnosis of cardiovascular diseases, along with the high cost involved in the procedure of cardiac biomarker, lack of full proof assurance, and steep competition among existing players dealing with cardiac biomarker.

Market Segmentation

The Global Cardiac Biomarker Market is segmented further based on Product, Type, Location of Testing, Application, and Geography.

By Product, the market is classified as Reagents & Kits and Instruments. Amongst the two, the Instrument segment is estimated to hold the highest market share during the forecast period.

By Type, the market is classified into Myocardial Muscle Creatine Kinase (CK-MB), Troponins, Myoglobin, Brain Natriuretic Peptide (BNPS), HSCRP, and Others. Amongst all, Troponins segment is estimated to hold the highest market share during the forecast period.

By Location of Testing, the market is classified as Laboratory Testing and Point of Care Testing. Amongst all, Laboratory Testing segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others. Amongst all, Acute Coronary Syndrome segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment - 28th April 2021

Company Profiles

Some of the companies covered in this report are Abbott Laboratories, Beckman Coulter, Inc. bioMérieux SA, Johnson and Johnson, Olympus Corporation, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Cardiac Biomarker Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market